MedPath

Evaluation of a High Protein Plant Dominant Diet (HiProPlaDo) in Liver Cirrhosis

Not Applicable
Recruiting
Conditions
Liver Diseases
Cirrhosis, Liver
Sarcopenia
Malnutrition; Cachexia
Registration Number
NCT07028580
Lead Sponsor
Agricultural University of Athens
Brief Summary

The aim of the study is to compare the implementation of a high-protein diet based on plant-based foods (Group A) with the usual guidelines for liver patients, in which protein needs are met by low-fat animal foods (Group B). The parameters that will be studied concern:

1. Liver function

2. Nutritional status and the risk of malnutrition

3. Body composition, with emphasis on muscle mass

3. Muscular system functionality and sarcopenia 4. The intestinal microbiome 5. The quality of life of the patients

This is a randomized, double-blind intervention study lasting 6 months, during which volunteers will be asked to answer, with the help of the researchers, questionnaires assessing nutritional risk, assessing physical activity and quality of life, and assessing nutritional intake (24-hour food recall and Food Frequency Questionnaire). At the same time, a blood sample will be collected for analysis of inflammatory factors and indicators related to nutritional status (albumin, prealbumin, cholesterol, total iron binding capacity). Body composition will be assessed using the method of anthropometry and dual-energy X-ray absorptiometry (DEXA), and hand dynamometry to assess functionality. The assessment of the microbiome will be performed by saliva collection and/or stool collection. The impact on liver function will be assessed by recording every 3 months a) natriuresis/microalbuminuria (in 24-hour urine collection or urine sample) and the severity of ascites (grade I, II, III), b)ammonia levels and episodes of encephalopathy, c) complications of cirrhosis, such as variceal hemorrhage, encephalopathy, spontaneous bacterial peritonitis and renal dysfunction, d) liver disease severity assessment scores, such as MELD and Child-Pugh scores.

The aim of the study is to see if there is a difference in sarcopenia and the values of various biochemical indicators between patients who received plant-based proteins compared to patients who received animal-based proteins.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
100
Inclusion Criteria
  • Adult patients with decompensated cirrhosis awaiting kidney transplantation who have not previously received dietary advice.
Exclusion Criteria
  • Psychopathological illness
  • Adoption of a vegetarian diet prior to study entry
  • Hepatonephrotic syndrome requiring protein restriction

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Anthropometric measurementsFrom the first day and 3 months later

The following parameters will be measured and combined into various equations to evaluate the body weight and body composition of each patient, body weight (kg) , height (m\^2) , mid-arm circumference (cm) , skinfolds (mm), dynamometry and biochemical/hematological testing were performed.

Quality of life (QoL) assessmentFrom the first day and 3 months later

Quality of life (QoL) was assessed with the SF-36 questionnaire.

Dietary complianceFrom the first day and 3 months later

Dietary compliance was assessed with 24-hour recalls and a food frequency questionnaire.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (2)

Laikon General Hospital of Athens

🇬🇷

Athens, Attica, Greece

Agricultural University of Athens

🇬🇷

Athens, Attica, Greece

Laikon General Hospital of Athens
🇬🇷Athens, Attica, Greece
Evangelos Chologitas, Professor
Contact
+30213 206 1643
cholongitas@yahoo.gr

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.